Latest Episodes
36
Episode 36: Zak Kohane, Department of Biomedical Informatics at Harvard Medical School
"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...
35
Episode 35: Charlene Son Rigby, CEO at Global Genes
"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh,...
34
Episode 34: Dan Mandell, CEO at GRO Biosciences
"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....
33
Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals
32
Episode 32: Stephanie Wisner, Author, Co-Founder at Centivax
"In research or in biotech, time is expensive. Time is the most expensive thing that you have." - Stephanie Wisner, Author, Co-Founder at Centivax...
31
Episode 31: Pam Cusick, SVP, Rare Patient Voice
"What can I contribute that my doctor can't contribute? And that's a real 'a-ha' moment when we share with them how they're the experts...